Find what you want here:-

http://passfans.com/forum/?fromuid=3450
Find what you want here:-
http://passfans.com/forum/?fromuid=3450
Index
1stDegree AV Block; C15
2nd Degree AV Block; C15
24-hour pH monitoring; G5
3rdDegree AV Block; C16
A
c--amltrvpslnDeficiency; G33, G38
AbdominalDistension; G2
Abdomi nal Mass; GS4
Abdominal Pain; ER22, FM11
AbdominalTrauma; ER14
Abducens Nerve Palsy; N22
Abnormal Uterine Bleeding (AUBI; GY6, GY15
Abortion; ELOAM14
Abscess; ER19
AbsoluteNeutrophil Count IANC); H7
Absolute RiskIncrease; PH19
Absol uteRisk Reduction; PH19
Abrasions; ER18, PL8
AbruptioPlacentae; OB24
AbscessDrainage; DM25
Abuse; GM3
Acalculous Cholecystiti s;GS43
Acanthocyte; H3
Acanthosis Nigricans; 041
Accessory Nerve; N24
Accuracy; PH13
Achalasia;DM15, G6
Achilles Tendon Rupture; OR36
Achilles Tendonitis; OR36
AcidFast Bacillus (AFB); ID2; NS13
Acne Vulgaris; D12, FM11
Acoustic Neuroma; OT15
Acromegaly; E18, RH4
Acromioclavicular; OR13
ActinicKeratosis; D6
AcuteAbdomi nalPain; GS4, G2
AcuteConfusional State; N13
Acute Coronary Syndrome; C2
AcuteFattyLiver of Pregnancy IAFLP); OB18
AcuteInterstitial Nephritis lAIN); NP27
AcuteLymphoblasticLeukemia IALL); H37
AcuteMyeloidLeukemia [AML); H31
AcuteOtitisMedia(AOM); OT38, P51, FM47
Acute Pyelonephritis; ID21
AcutePain; A18
AcuteRespiratoryDistressSyndrome (ARDS); DM6
Acute RetroviralSyndrome; ID30
AcuteTubular Necrosis IATN); G39, NP25, NP26
Acute Viral Hepatitis; G31
Adie'sToni c pupil; N29
Addison's Disease; E35
Adenomyosis; GY18
AdhesiveCapsulitis; OR14
Adolescent Medicine; P16
AdrenergicInhibitors; ER33
Adrenocorti cal Hormones; E30
Adrenocortical Insufficiency; E355
Adrenocorticotropi nHormone IACTH); E30
Advanced Directive; ELOAM18
Adverse Drug Reactions (ADRsl; GM12, CP12, CP13
AdynamicIleus;DM14
Aerobes: \02
Afferent LoopSyndrome; GS16
Age-Related Macular Degeneration; OP29
Aging; GM2
Agitation; A17
AgnogenicMyeloidMetaplasia; H36
Agnosia; N16, N20
Agonists;CPS, CP10
Agranul ocytosis; H8
AIDS; ID28
Air Bronrnoqrams: OM5
AirSpaceDisease; DM5
Airway Management; ER2
Toronto Notes2008
Albumin-CreatinineRatio(ACR); NP35
Albuminocytological Dissociation; N6
Alcohol; G38, FM9
Alcohol Abuse; G37
Alcohol Intoxication; ER23
Alcohol Pancreatitis;ER24
AlcoholWithdrawal; ER23
AlcoholicKetoacidosis; ER24
Alcoholic Liver Disease;G37
Aldosterone; E30, NP15
AllergicReactions; ER26
AllergicRhinitis; FM1 2
Alopecia; 043, 044
Alveolar-Arterial 0, Gradient; A10
Alzheimer'sDisease; N15, N16
AmaurosisFugax; OP40, N25
AmbiguousGenitalia; P30, U38
Amblyopia; OP43
AmenorrhealOligomenorrhea; GY6, 14
American Academy of Neurology (AANI; NS31
Amiloride; NP38
Aminoglycosides; 1047
Amniocentesis; OB9
Amniotic RuidEmbolus; 0848
Amsterdam Criteria; G30
Amyloidosis; NP22, NP25
AmyotrophicLateral Sclerosis (ALS); N38
Anaerobes; 102
Anaphylaxis; ER26
AnagenEffluvium; D43
Anal Fissures: GS34
Anal Neoplasms; GS37
AnalgesicLadder; A18
Analgesics/Non-narcotic; GM13
Analysis of Variance; PH13
AndrogenInsensitivity; E50
Androgens; E31
Anemia;P46, H3, H47
Anemiaof ChronicDisease; H12
Angelman Syndrome; P44
Angioedema;025, ER26
Angiodysplasia; GS32, G29
Angiography; DM24, C12
Angiomyoli poma; U17
AngiotensinII IAII); NN, NP33
Angular Gyrus; N18
Anhedonia; PSB
Anion Gap; ER48
Anisocoria; N28
Anisometropia; OP10
Ankle-Brachial Index; C47
AnkleFracture; OR34
AnkylosingSpondylitis (AS);RH19
AnnArbor Staging System; H38
Anorectal Abscess; GS34
Anosmia; N20
Antagonist; CPS, CP1 0
Antenatal Hydronephrosis; U35
Anterior Cerebral ArteryStroke; ER36
AnteriorCordSyndrome; NS24
AnteriorIschemicOptic Neuropathy; N24
AnteriorShoulderDislocation; ER16
Anti-Centromere; RH11
Anti-Hypertensives; GM13
Anti-La; RH14
Anti-Mycobacterials ; 1048
Anti-Ro; RH14
Anti-RNP; RH15
Anti-Topoisomerase; RH11
Antiarrhythmics; C56
Antibiotics; 1046, FM47
Antibody; RH11
Anticardioli pin; RH11
AnticoagulantTherapy; H48
Anticholinergics; ER50
AntidiureticHormone(ADH); E19
Anlifungals; ID50
Antiparasitics; ID51
Antiphospholipid AbSyndromeIAPLAS); H6, H30, N35,
RH10
AntiplateletTherapy; H47
Antipsychotics; PS41
AntiretroviralTheraphy; ID33
Antivirals; 1049
Anxiety; FM13
AorticAneurysm; C49
AorticArch Syndrome;RH17
AorticDissection; 00, ER28
AorticInsufficiency; C41, RH21
AorticStenosis; C41, P21
AorticTear; ER13
Aortoenteric Fistula; G27
Aphasia; N16, N18
AplasticAnemia; H14
ApocrineSweatGland; 02
Apolipoprotein B; E1 5
Appendicitis; DM17; GS24
Apraxia; N16, N19
ArcuateFasciculus Associ ationBundle; N18
Argyll-Robertson; N29
Arterial Lines; R34
Arterio-VenousFistula; NS20
Arteriovenous Malformations;NS20
Arrhythmias; C14
Arterial Blood Gases; R4
Arterial Occlusion/Insufficiency; C45
Asbestos; DM7, R26
Asbestosis; R16
Ascending Cholangitis; G46
Ascites; DM13, G42, G45
Aspergillosis; R15
Aspergillus; 1037
Astereognosis; N20
Asthma;ER26, ER44, FM14, P89, R6
Astigmatism; OP10
AstrocyticHypoplasia; DM20
Asymptomatic Carotic AtherosclerosisStudy; NS20
Asymptomatic Carotid SurgeryTrial ; NS20
Ataxia; N58
AtaxiaTelangiectasia; N48
Atelectasis; DM6
Atherosclerosis; C23
AtopicDermatitis; D14
Atrial Fibrillation; C18, N57. N63
AtrialFlutter; C17
Atrial Septal Defect (ASD); P20
AttackRate; PH14, PH15
AttributableRisk; PH9
Augmentation of Labour; OB39
Aura; N9
Autoimmune;G38
Autoimmune ChronicActiveHepatitis; G34
Autoimmune HemolyticAnemiaIAIHAI; H18
Autonomi c;CP16
AutonomicNervous System (ANSI; CP14, CP15
Autonomy; ELOAM6, ELOAM7
Autosomal Recessive Polycystic Kidney Disease;NP37
AV ConductionBlocks; C15
AVNodal Reentrant Tachycardia; C19
AVReentrantTachycardia; C19
Avascul arNecrosis; OR7
Avian Influenza; ID13
Avulsi ons; PL8
Azotemia; NP4
Index 1
2 Index B c Toronto Notes 2008
B
B12; H47
H1 5H16
Back Pain; OR22
Bacterial Overgrowth; G20
BacterialPeritonitis; G42
BacterialTracheitis; ER43, P87
BalanitisCircinata; RH20
Balkan (endemic) Nephropathy; NP25
BambooSpine; RH19
Bariatric Surgery;GS16
Barrett's Esophagus;G5, G7
Bartholiniti s/BartholinGland Abscess;GY30
BariumEnema; G52
Basal CellCarcinoma; D36
Basal Ganglia; N29
BasophilicStippling; H3
Battery; ELOAM15, ELOAM16
BatwingPattern; DM6
Beck'sTriad; C44
Becker's MuscularDystrophy; P45
BeersCriteria; GI\112
Bell'sPalsy; N22
Beneficence;ELOAM6, ELOAM7, ELOAM11
BenignBoneLesions; DM11
BenignIntracranial Hypertension; NS8
BenignProstaticHyperplasia(BPH); FM15; U5
Bennett'sFracture; PL16
Benzodiazepines;A25
BemsteinTest;G5
Bifascicular Block; C6
Biguanide; E52
BileAcidSequestrants; E53
BiliaryAtresia; P70
BiliaryColic; GS42
BioavailabilityIF); CP3
Biophysical Profile(BPP); OB6, 7
BioprostheticValve; C40
Biotransformation; CP5
BiPAP(bilevelpositiveairway pressure); R28
Bisphosphonates; E54
Bites;PL10
Bladder, N65
Bladder Carcinoma; U20
BladderCatheterization; U39
BlastomycesDermatitidis; ID36
Blepharitis; OP15, FM4B
Blind-LoopSyndrome; GS16
BodyMass Index (BMU; FM5
BloodBrainBarrier; NS37
BloodGlucose; fm22
BloodTransfusionReactions; H45, H46
BloodProducts; A15, H44
BochdalekHernia; DM8
Boerhaave'sTear; DM1 5
BoneAbscess; DM11
BoneMineral Density; DMll
BoneScan; DM22
BoneTumours;OR41
Bouchard'sNodes; RH5
BoutonniereDeformity; PL14, 15; RH7
BowelObstruction; GS20
Boxer'sFracture; Pl16
BPPV;OT13
Brachial Plexus; PL4, NS28
Bradyarrhythmias;C15
Bradykinesia; N31
Branchial Cleft Cysts; OT33
Breast Feeding; P6, P8
BreastCancer; GS50
Breast Lesions; GS49
Breast Reconstruction;PL30
BreathHoldingSpells; P14
Breech Presentation; OB42
Broca'sArea; N18
Brodie'sAbscess; OM11
Bronchlectasis; Rl0
Bronchiolitis; P88
BronchiolitisObliteransWith Organizing
Pneumonia(BOOPI; R15
Bronchitis; R9,FMt6, 47
Bronchodilators; R9
Bronchogeniccancer; R31, R32
BronchogenicCarcinoma;R29
Bronchopulmonary Dysplasi a; P67
Bronze Diabetes; G37
Brown-SequardSyndrome; NS24
BuddChiari; G39, G42
BullousPemphigoid; D21
Bunions; OR37
Burns; ER20, Pl19
Burr Cell; H3
c
C. difficile; G15
Csplnex-ray; ER10
CABG; C30
Caesareansection;A22; OB51
CAGE; PS20
Calcaneal Fracture; OR35
Calcitonin; E39, E54
Calcium; E39, E55
Calciumchannel Blocker (CCB), NS37
Call ouses; D34
CaloricandFluidRequirements; GMB
CaloricReflexes CONS; N7
Canada Health Act; ELOAM2, ELOAM3
CanadianC-SpineRul e,The; ER10
Canadian Medical Association ICMAI; ELOAM4
Canadian Medical ProtectiveAssociation (CMPA);
ELOAM4
Cancer; G29
Candida; G8
Candida Albicans; 1037
Candidiasis; D35
Canmeds; ELOAM12
Capabl e; ELOAM8, ELOAM16
Capacity; ELOAM8, ELOAM9, ELOAM16, ELOAM17
Capsular Contraction; PL31
Caroamazepine; N1 2
Carbapenems; 1047
Carcinoma of theGallbladder; GS45
CardiacAnatomy; C4
CardiacCatheterization;C12
CardiacEnzymes; C9, ER28
CardiacMurmur; C4
CardiacTamponade; CM, ER12
CardiacTransplantation; C32
CardiacTrials; C57
Cardiogenic Shock; ER3
Cardiomegaly; DM8
CardiopulmonaryBypass; C31
CardiothoracicRatio; DMB
CardiovascularShadow; DMB
Carotid Stenosis; NS19, NS31
CarpalTunnel Syndrome; Pl17, NS2B
Case-Control Study; PH17, PH18
Case-Fatality Rate; PH14,PH15
Casts; NPS
Cat Scratch Disease; ID27
Cataracts; OP23
Catatonic; PS3
CaudaEquinaSyndrome; RH19,RH21, NS26
Cavernous Malformation; NS20
CD4; ID29
CeliacDisease; G19, P38
Cellulitis; ER19, PL24, FM4B
Central/Branch RetinalVein Occlusion; OP27
Central Cord Syndrome;NS24, NS35
Central DI; E19
Central Retinal ArteryOcclusion; 0P26
Central Shadow; DM5
CentralVenous Access; DM24
Central VenousCatheter; R34
Cephalosporin;1046
Cerebello-Pontine Angle (CPA); NSll
Cerebellar Ectopia; NS35
Cerebral Abscess; NS12
Cerebral BloodFlowICBF); NS5
Cerebral Palsy (CPI; PS2
Cerebral PerfusionPressure; NS5
CerebrospinalFluid ICSF); NS4
Cervical Cancer; GY46
Cervical DiscSyndrome; NS25
Cervical Radiculopathy; OR21
Cervical Stenosis{Cervical Spondylosis}; NS23
Cervical Lesions; GYM
Cervical Spine; OR20
Cestodes; 1042
Champix'": FM9
Charcot Joint; RH4
Charcot'sTriad; N64, G46
CHARGE association; P45
Chemical Burn; PL23
ChemotherapeuticAgents; H50
Chest Pain; E4, C29,ER27, FM16
ChestTrauma; ER1 2
Chi-squareTest; PH13
Cbiari Malformations; NS35
ChickenPox; 044, ER43
ChildAbuse; ER44, P15
ChildPugh Classification; G41
ChildhoodEpileptic Syndromes; P79
Chlamydia; GY27
Cholangiocarcinoma; GS45, G44
Cholangitis; GS44
Cholecystitis; DMl7, GS42
Cholecystostomy; DM25
Choledocholithiasis; DM16
Cholesteatoma; OT1 8
Chol elithiasis; GS41
Chol edocholithiasis; GS43
Cholinergics; ER50
Chondrocalcinosis; G37, RH23
Chondrosarcoma; DM10
Chorea; N35
Chorioamnionitis; OB49
ChorionicVillus Sampling(CVS); OB10
Chronic Bronchitis; ER28
Chroni cFatigueSyndrome; RH25
ChronicLymphocyticLeukemia (CLL); H41
ChronicMyeloidLeukemia; H35
ChronicObstructive Pulmonary Disease; R8, ER28
ChronicPelvicPain Syndrome;U11
Chroni cJRecurrentAbdonimal Pain; G2
ChronicSinusitis; OT28
Chronic StableAngina; C23
Chronic Venous Insufficiency; C53
Churq-Strauss Syndrome(AllergicGranulomatosis
and Angiitis); R21
CircleofWillis; NS3
Circumcisi on; P1 2
Cirrhosis;DM16
aWA;PS21
Oaudication; E4
Clang Associations; PS3
Claudication; OR23
Clavicular Fracture; OR13
ClawToe; RH7
Cl earance; CP7, CP8
Cl eftLip; PL33
Cleft Palate; PL33
Clobazam; N12
Clonazepam; N12
ClusterHeadache;N56
CMA; ELOAM4, 7, 11 , 14, 19
CNS Infections: N57
CoagulationFactors; H45
Coal Worker'sPneumoconiosis;R17
Coarctation of theAorta;P21
CobbAngle; OR41
Cobblestone Mucosa; G21
CocaineTest; N2B
CoccidioidesImmitis;ID36
Cockcroft-Gault Equation; CP6
Codeine; A25
Codman'sTriangle; OR41
CoffeeBeanSign; DM14
CognitiveEnhancers; GM14
Cohort Study; PH17, PH18
Colic; PlO
Colitis;G29
Toronto Noles2008
Collateral LigamentTears; OR30
College of Physicians &Surgeons of Ontario
(CPSOI; ELOAM4
Colles' Fracture; OR18, ER16
Colon Cancer; G29
ColonCut-Off Sign; G49
Colonoscopy; G52
Colorectal Carcinoma;GS30
Colorectal Polyps; GS29
Colposcopy; GY11 , GY46
Coma; N7, ER25
Comedones; 04
Common Cold (AcuteRhinitis); FM17
CommunityAcquiredPneumonia; FM48
CommunityDevelopment; PH6
CommunityMedicine; PH2
Compartment Syndrome; OR9, ER16, PL14
Complementary and AlternativeMedicine (CAM);
FM46
Compl exPartial Seizures;N8
Complex Regional PainSyndromes ICRPS);N52
Complicationsof GastricSurgery; GS16
Compulsions; PS15
Computed Tomography (Cn;DM2
Conduction Abnormaliti es; C6
ConductiveHearingLoss; OT10
Confidence Interval; PH13
Confidential ity;ELOAM7, ELOAM18
Confusion; A17, PL8
Confusion/Delirium; GM6
Congenital Adrenal Hyperplasia (CAH); P30
Congenital Cardiac Disease; C45
Congenital Cyanotic Heart Disease (CCHD); NS12
Congenital Heart Disease ICHDI; P18
CongenitalTal ipes Equinovarus; OR4O
Congestive Heart Failure (CHF); C33, ER29
Conjunctivitis; OP16, RH10, RH21, FM48
Conn's Syndrome; E32
Coning; NS6
Consent; ELOAM7
Consent and Capacity Board; ELOAM17
Consent Flowchart; ELOAM8
Consolidation; DM5
Constipation; GM11, G3, G26, P39
Constitution Act; ELOAM2
Constrictive Pericarditis; CM
Contact Dermatitis; D17
Contaminants; PH21, PH22
Contraception; GY19, FM18
Conventional Fractionated Radiotherapy (XRT);
NS9
Cor Pulmonale; CB
Corkscrew Pattern; G6
Corkscrew Sign; DM14
Corneal Abrasion; OP19, ER33
Corneal Reflex; N7
Corneal Ulcer; 0P20
Corns;D34
Coronary Circulation; C3
Coroner; ELOAM18, ELOAM20
Coroner's Act; ELOAM20
Corticosteroids; NP21
Cortisol; E31
CosyntropinStimulationTest; E32
Countertransference; PS40
CPAP (continuouspositive airway pressure); R28
CPSO; ELOAM4, ELOAM11, ELOAM20
Cranial Nerve Injury; NS30
Craniofacial Injuries; PL27
Craniosynostosis; PL33, NS35
CREST Syndrome; G45, RH5, RH11
Criqlsr-Naijar Syndromes
Type I and 11; GM
Crystal-Induced; RH3, RH22
Crystals; NPS
Critical Appraisal; PH19
Crohn's Disease; GS25, G9, G13, G20, G21, G24,
RH21
Cross-Sectional; PH16, PH18
Croup; OT45, ER43, P87
Cruciate LigamentTears; OR30
Crude death rate; PH11
C D E
Crush Injuries; PL8
Cryoglobulinemia; NP23, NP25
Cryptococcus Neoformans; ID37
Cryptorchidism; U37
Cryptosporidium spp,; ID40
CSF; ID7
CT Angiogram (CTA);NS20
CT Colonography; DM15
Cullen's/Grev-fumers' Signs; G48
Cushing's Disease; E33
Cushing's Syndrome; E33
Cushing'sTriad; ER8
Cushing' sUlcers; G12
CutaneousT-Cell Lymphoma; D37
Cyclophosphamide; NP21
Cystic Fibrosis(CF); R11, P90
CysticHygroma; OT33
Cytoid Bodies; RH10
Cystoscopy; U39
Cytochrome CYP sndP450 System; CP5
Creutzfelt-Jacobdisease; N15
D
Dactylitis; RH18, RH20
Dandy-WalkerMalformation; NS34
Danis-WeberClassification; OR34
De Quervain'sTenosynovitis;PU5
Death Rattle; GM11
Debridement PL9
Deep Brain Stimulation(DBS); PS51
Deep (Costophrenic)Sulcus; DM7
Degenerative Arthritis; Osteoarthritis; RH4
Dehydration; A14, P72
Delayed Puberty; P32
Delirium; N13, ER25
DeliriumTremens IDTI; ER23
Delusion; PS3
Delusional Disorder; PS6
Dementia; N14, ER25
Dental Infections; FM48
Depersonalization; PS3
Depressed Hemidiaphragm; DM7
Depression; FM19, PS8
Derealization; PS3
DermatitisHerpetiformis; D22
DermatomesiMyotomes; NS21
Dermatomyositis; RH5
Dermatofibroma; D5
Dermatophytes; D30,D31 ; ID34
Dermis; D2
Detrusor-SphincterDyssynergia(DSD); U7
Developmental Delay; P25
Developmental Dysplasiaof theHip; OR39
Developmental Milestones; P4
DEXA; RH8
Dexamethasone;ID7
Dexamethasone(DXMj SuppressionTests; E31
DiabetesInsipidus (DI); E19, P28, NS31, NP13
Diabetes Mellitus(DM); E3, P27, FM20
DiabeticFoot; ID23
DiabeticKetoacidosis (DKA);E7, ER30
DiabeticNephropathy; E9, NP35
DiabeticNeuropathy; E10, N42
DiabeticRetinopathy; E8
Diagnosti cPeritoneal Lavage (DPL);ER14
Dialectical BehaviourTherapy; PS41
DiaphragmaticHernia; P67
Diarrhea; ID16, G3, G2, G13, G15; P36, P37
Diastol icDysfunction; C33
Dieulafoy'sLesion; G27
Diffuse Axonal Injury/Shearing; NS31
Diffuse Esophageal Spasm; G6
DiGeorge Syndrome; PM
Digital Block; ER19
Digitalis; C9
Dilatation and Curettage (D&C); GY12
Dilated Cardiomyopathy; C36
Diplopia; N27
Disability; PH4
Disability adjusted lifeyear; PH10
Index 3
Disease; PH4
Disease-ModifyingTherapy (DMT); N65
DiscHerniation; OR22
Disclosure; ELOAM9, ELOAM10
Discontinuation Syndrome; PS48
Dislocated Knee; OR31
Dislocations; PL16
Disseminated Intravascular Coagulation [DIC); H27
Distribution; CP4
Distributive Shock; ER3
Diverticula; G6
Diverticulitis; DM17; GS27
Diverticulosis;DM15, GS27
Dizziness; OT6, FM23
Doctor-Patient Relationship; ELOAM11. ELOAM15
DomesticViolencelElderAbuse; FM24
DonepeziIIAriceptT"I ; N16, N17
Doppler;DM3
Dose-Response; CPS, CP9, CPIO
Double Diaphragm Sign; DM7
Doubl eOutlet Right Ventricle;P23
DoublingTime; DM7
Down syndrome; P43
DrivingCompetency; GM9
Drug Absorption; CP3
Drug-Induced Liver Disease; G34
Drug Overdose; ER51
Drug Response; CP13
Drug Sensitivity; GM12
Dry Eye Syndrome; OPl2
DryMouth; GM11
Dual X-Ray Absorptiometry (DEXA);DM11
Duane'sSyndrome; N22
Ductal Carcinoma inSitu (DCIS); GS52
Duchenne and Becker Muscular Dystrophy; N46
Duchenne-Erb Palsy; PL18
Duchenne Muscular Dystrophy; PM
Duke Critera; ID15
Dumping Syndrome; GS16
Duodenal Atresia; P25
Duodenal Ulcers; GS13, G53
Duplex Scan; DM3
Dupuytren's Disease; PL17
Dural;A20
DiethylstilbestrollDES) Syndrome; GY49
Dialysis; NP32
Dysarthria; N19, N47, N58
Dysfunctional Uterine Bleeding IDUB); GY15
Dyshidrotic Dermatitis;D17
Dyskinesias; N32
Dyslipidemias; E12, FM6
Dysmenorrhea; GY8, GY16
Dysmorphisms; P42
Dyspareunia; GY9
Dyspepsia; G3, G4
Dysphagia; GM11, N19, G2,G4
Dyspnea; GM11, C5
Dysrhythmias;P24
Dysuria; fm26
Dystonia; N36
E
EColi; ID1 6
Early Goal DirectedTherapy: R37
Ebstein'sAnomaly; P22
Eccrine Sweat Gland; D2
Echinocyte; H3
Echocardiography; C10
Ecological Study; PH16, PH1 8
Ectopic Pregnancy; OB26
Ectropion; OP15
Edema Generalized/Local; C4
Edwards syndrome ; P43
Effectiveness; CP11 , PH19
Efficacy; CP8, CP, PH19
Efficiencv; PH19
Efflux Pump; CP4
Ego-dystonic; PS15
Elbow Dislocation; OR16
Elder Abuse; FM25
4 Index
Electrical Burns; PL23
Electrical Pacing; C2l
Electrocardiography (ECG); E5
ElectronicFetal Heart Rate(FHR) Monitoring; OB35
Electromyography (EMG); NS23
Electrophysiology StudiesIEPS);C2l
Elevated Hemidiaphragm; DM7
Elimination; CP6, CP7, crs
Elliptocyte; H3
Embolization; DM24
EMDR; PS16
Emergency Contraception(EC); FM19
Emmetropia; OP9
Emphysema; R9, ER28
Emphysematous Cholecystitis;DM13
Empty Sella Syndrome; E20
Empyema; R25
Encephalitis; 108
Encephalopathy; G32
Encopresis, P13
End of LifeCare; GM10, GMll
Endocardial Cushion Defect; P21
EndometrialAblation; GY13
Endometrial Carcinoma; GY39
Endometrial Stromal Sarcoma; GY40
Endometriosis;GY17
Enophthalmos; OP11
EntamoebaHistolytica; ID38
Enteral Nutrition; G51
Enteroviral; 047
Enthesitis; RH4, RH18
Entropion; OP14
Enuresis; P13
Enviromental Health; PH20
EosinophilicPneumoni a; R15
Epicondylitis; OR17
EpididymitisandOrchitis; Ull
Epidemic; PH14, PH15-6
Epidermis; D2
Epidural; A20
Epidural Hematoma; DM19
Epiglottitis; OT45
Epilepsy; N9
Episcleritis; OP18, RH10
Episiotomy; OB50
Epispadi as-Exstrophy Complex; U35
Epistaxis; OT25, G27, FM27
Epithelialization; PL9
EPS; PS44, PS45, PS50
ERCP; DM16
ErectileDysfunction; U30, FM27
Erickson; PS33
ErosivePeptic Ulcer; DM13
Erysipelas; PL24
Erythema Infectiosum; D45, ER43, P60
Erythema Multiforme; D24
Erythema Nodosum; 045
Erythropoietin; H5, H47
Esophageal Adenocarcinoma; G5
Esophageal Carcinoma; GSll
Esophageallnjury; ER13
Esophageal Perforation; GSll
Esophageal Tear; DM15
Esophageal Varices; G27, G28
Esophaqiti s:DM15, G27
EsscntialThrombocythemia lET); H37
EssentialTremor; N34
Ethical; ELOAM10, ELOAM14
Ethics; ELOAM6, ELOAM10
Ethosuximide; N12
Euthanasia; ELOAM13
Ewing'sTumour; DM10
Exacerbationsof COPD; Rl0
Exercise; FM8
ExerciseTesting; Cll
Excoriation; 03
Exophthalmos: OPll
Exostoses; 0T16
Exposure Pathway; PH21
ExtensorTendons; Pl3
Extinction; PS41
E F G H
Extra-Ocular Movements (EOMI; NS5
Extradural lEpidurall Hematoma; NS13
Extrapyramidal Side Effects; PS45
Exudative Pleural Effusions; R23
Ezetimibe; E53
F
Facial Nerve; OT4, N22
Facial Nerve Paralysis; OT22
Factitious Disorder; PS25
FactorVLeiden; H30
Failure toThrive; GM3, GM4, P9
Falls; GM5, GM6
Familial ColonCancer Syndromes; GS29
Fami lialHypocaiciuricHypercal cemia;E40
FamilyTherapy; PS41
Fanconi 'sSyndrome; G36
Fatigue; FM29
Febrile Infant; ER41
Febrile Neutropenia; ID44
Febrile Seizures; N9; ER42;PaO
Fecallncontinence; GM5
Felon; PL25
Femoral Fracture; OR28
Fentanil ;A25
Fetal Alcohol Spectrum Disorder (FASD); P27
Fetal EthicallyAppropriate; ELOAM13
Fetal Ri ghts; ELOAM13
Fever; P51
Feverof Unknown Origin; ID45
Fibrates ; E53, FM7
Fibrinolysis; C27
Fibroadenoma; GS49
Fibrocystic Change; GS49
Fibromuscular Hyperplasia; NP33
Fibnomyalgia; RH25
Filtration Fraction(FFI; NP4
Finger Agnosia; N20
FirstTrimester Screeen (FTS); OB7
Fistula; GS33
Fistula-In-Ano; GS35
Fitzpatrick's Sign; 05
Flail Chest; ER12
Flaps; PL12
FlexorTendons; PL3
Flight of Ideas; PS3
Flooding;PS41
Fluid Balance; A1 3
Fluid and ElectrolyteTherapy; P73
Fluoroquinolones; 1048
Fol ate Deficiency; H20
FolicAcid; H47
FolieaDeux; PS7
Follicle StimulatingHormoneIFSH); E19
FoodPoisoning; 1018
Football Sign; DM13
Form 21; ElOAM17
Form 24; ELOAM17
Fractures; OR5
Fanconi'sSyndrome; NP25
Friedreich'sAtaxia; N48
Fragile XSyndrome; P44
Fresh FrozenPlasma; H45
Frontotemporal Dementia; N1 5,N17
Frostbite; ER39, PL23
Frozen Shoulder; OR13
FullThickness Skin Graft; PSll
Fulminant Hepatic Failure; G32
Fungal Infections; 1034
Fungi; ID5
FurosemideILasix ); NP38
Fusion Inhibitors; ID33
TorontoNotes2008
G
G6PD Deficiency; H19
Gabapentin; N12
Gait; GM6
Gag Reflex; N7
Galactosemia; P46
Galantamine (ReminyI TM); N16
Galeazzi Fracture; OR18
Gallstone Ileus; GS44
Gallstones; G44
Gamekeeper'sThumb; PL17
Ganglion Cyst; Pl15
Garden Classification; OR25
Gardner'sSyndrome; G30
Gastric; G53
GastricCancer; G27, GS14
GastricSarcoma; GS15
GastricUlcers; GS13, G27, G53
Gastritis;G9, G27
Gastroesophageal Reflux; P36
Gastroesophageal Reflux Disease (GERD);
G4, G53 RH12
Gastrojejunostomy; DM25
Gastroscopy; G5, G51
Gastrostomy; DM25
Gaucher's; G39
Generalized Seizures; N8, N10
GeneticTesting; ELOAM14
Genitourinary IGU); NS33
Geriatric Giants; N14
Gerstmann's Syndrome; N20
Gestational Diabetes Mellitus; OB13
Gestational Hypertension;OB14
GestationalTrophoblasticNeoplasiaIGTNI; GY49
GIBleed; DM23; GS4
Giant Cell (Temporal)Arteritis; N25; OP41 ;
RHl7, RH24
Gianotti Crasti Syndrome; D45
Giardia Lamblia; G15; 1039
Gilbert's Syndrome; G44, G45
GilliesApproach; PL29
Glasgow ComaScale; N7, ER4, NS5, NS29
Glaucoma; OP30
Glioblastoma Multiforme(GBM); NS10
GlomerularBasement Membrane (GBM); NP2
GlomerularFiltration; CP6
Glomerulosclerosis; NP35
Glossopharyngeal Neuralgia; N23
Gluten Enteropathy; G19
Gonococcal Arthritis; ID22
Gonococcemia; D29
Gonorrheal Chlamydia; FM48
Goodpasture'sSyndrome; R22, NP23
Gottron's Papules; RH1 3
Gottron's Sign; RH13
Gram Stain; ID2
Grand Mal Seizure; Nl0
Graves' Disease; OP40, E23
GroupPsychotherapy; PS4l
Growing Pains; P92
GrowthHormone (GH); E18, P33
Guillain-BarreSyndrome (GBS); N4l
GunshotWounds; ER7
GustiloQassifi cation; OR8
Guyon's canal; NS28
Gynecomastia; E51
H
H.pylori-InducedUlcerati on; Gl0
Half-Life; CP7, css
Hallucination; PS3
Hematuria; ER15
Hamman's Sign; ER13
HammerToe; RH7
Hampton's Hump; ER28
Hand, Foot and Mouth Disease; D45
Handicap; PH4
Hansen's Disease; ID25
Toronto Notes 2008
Harm Reduction; PH7
Hashimoto'sThyroiditis; E27
Haustra; G12
Hb02 Saturation; A10
Head Circumference (HC); NS34
HeadTrauma; ER8
Headache; ER31, NS5, FM30
Health Belief Model; PH6
Health Care Consent Act; ELOAM15
Health Promotion; PH5, PH6
Health Promotion and Protection Act; PH3
Hearing Impairment; FM31
Hearing Loss; ono
Heart Borders; DM8
Heart Munmurs; P18
Heartburn;G5
Heat Exhaustion; ER38
Heat Stroke; ER38
Heberden's Nodes; RH5
HeinzBodies; H3, H19
HeliotropeRash; RH13
HELLP Syndrome; OB27
Helmet Cells; H3
He!minths; ID5
Hemachromatosis; G38
Hemangioma; D7; DM16
Hematemesis; G26
Hematocrit (Hct); H2
Hematochezia; G26, G29
Hematoma Blocks; A21
Hematuria; P74; NP5; U12, 13
Hemianopsia: N25
Hemifacial Spasm; N23
Herniated Disc; DM21
Hemochromatosis; G37, RH4, RH23
Hemodialysis; ER49, NP32
Hemoglobin(Hb); H2
Hemolysis; GM
HemolyticAnemia; H14
Hemolytic Uremic Syndrome (HUS); P75, H24
Hemoperitoneum; DM13
Hemophilia A; H25
Hemophi liaB; H26
Hemorrhage; DM3
Hemorrhagic Stroke; N61
Hemorrhoids; GS33, G29
Hemostasis; H20
Hemothorax; ER12
Henoch-Schbnlein Purpura; P94, NP23
Heparin; H48
Heparin-lnducedThrombocytopenia (HIT); H24
Hepatic Adenoma; DM16
Hepatic Encephalopathy; G40
HepaticFirst-Pass Effect; CP3, CP4
Hepatitis; G31
Hepatitis A; G35
Hepatitis B; G33, G34, G35; ID20
Hepatitis C; G33, G35, ID20
Hepatitis D; G34, G35, ID20
Hepatitis E; G35
Hepatocellular Carcinoma; G40
Hepatopulmonary Syndrome; G43
Hepatorenal Syndrome; G39
Hereditary Elliptocytosis; H19
Hereditary Non-Polyposis Colorectal Cancer
(HNPCC!; GS30
Hereditary Spherocytosis; H18
Hernia; GS18
Herniation; NS6
Hypera!dosteronism; NP19
Herpes; FM48
Herpes Simplex; D32
Herpes Simplex Encephalitis; ID8
Herpes Simplex Keratitis; OP20
Herpes Simplex OfVulva; GY29
Herpes Zoster; D33
Herpes Zoster Keratitis; OP21
HerpeticWhitlow; PL25
Hiatus Hernia; DM15, GS10, GS11
Hiccups; GM11
H
Hickmann; DM24
HIDA; DM23
Hidatid Cyst: DM16
Hila; DM5
HipDislocation; GR10
HipFracture; OR25
Hirschsprung'sDisease (Congenital Aganglionic
Megacolon); P39
Histoplasma Capsulatum; ID35
Histoplasmosis; ID35
HIV; 1028, N15, P53
HIV-Associated Renal Disease; NP22
HMG CoA Reductase Inhibitor; E53
Hoarseness; OT8, OT28
Hodgkin's; H38
Hodgkin's Lymphoma; H39
Hormone ReplacementTherapy (HRT); GY34
Homonymous; N25
Hordeolum (Stye); OP15
Horner's Syndrome; OP34, N5, N28
Hospitalization; GM6
Hounsfield Units; OM2
Howell-Jolly Bodies; H3
Human Papilloma Virus (hpv); GY28, FM41
Humeral Fracture; OR14
Huntington's Disease; N15, N35, N36
Hydatidiform Mole; GY50
Hydrocele; un
Hydrocephalus; NS7, NS34, NS35
Hydrochlorothiazide (HCTZ); NP38
Hydromorphone; A25
Hyperaldosteronism; E32
Hyperalgesia; RH25
Hyperandrogenism; E34
Hyperbilirubinemia; GM
Hypercalcemia; E40, C8
Hypercarbia; NS31
Hypercholesterolemia; E13, N63
Hypercoagulability; H28
Hyperemesis Gravidarum; OB16
Hyperglycemia; FM23
Hyperglycemic Hyperosmolar Nonketotic State
(HONK); E7; EER30
Hypergonadotropic Hypogonadism; E49
Hyperkalemia; C8
Hypernatremia; NP9
Hyperopia; OP9
Hyperparathyroidism; DM12, E40, RH4, RH23
Hyperprolactinemia; E19
Hyperreflexia, Ataxia, Nystagmus; N64
Hypersensitivity Pneumonitis; R15
Hypertension; FM32, GM7, N57, NP33
Hypertension inChildhood; P77
Hypertensive Emergency; ER32
Hypertensive Encephalopathy; ER32
Hypertensive Nephrosclerosis; NP33
Hypertensive Urgency; ER32
Hyperthyroidism; E22
Hypertriglyceridemia; E13
Hypertrophic Cardiomyopathy; C37
Hypertrophic Osteoarthropathy; RH21
Hypertrophic Scar; PL8
Hvperuricernia; RH22
Hyperviscosity Syndrome; H43
Hyphema; OP46
Hypnosis; PS41
Hypocalcemia; E42, C8
Hypokalemia; C8, NP14, NP15
Hypoglossal Nerve; N24
Hypog!ycemia; ER31
Hypogonadism; E49
Hypogonadotropic Hypogonadism; E49, G37
Hypogonadotropism; E19
Hypomagnesemia; E44, G50, RH23
Hypomanic Episode; PS8
Hyponatremia; NP9, NP10, NP12
Hypoparathyroidism; E42
hypophosphatemia; RH23
Hypoplastic Left Heart Syndrome; P23
Hypopituitarism; E20
Index 5
Hypospadias; U35
Hypothermia; C8, ER39
Hypothyroidism; E26, RH4, RH23
Hypotonia; P81
Hypovolemic Shock; ER3
Hypoxemia; NS31
Hysterectomy; GY11
Hysterosalpingography; DM2, GY10
Hysteroscopy; GY12
I
IBS; G26
Ictal; N8
Ideas of Reference; PS3
Idiopathic MyelofibrosisIIMF); H36
Idiopathic Pulmonary Fibrosis; R13
Idioventricular Rhythm; C20
Illusion; PS3
Immobility; GM7
ImmuneThrombocytopenic Purpura (ITP); P49, H23
Immunizations; GM7, P5
Immunocompromised; 1043
Immunodeficiency; ID30
Impairment; PH4
Impaired Fasting Glucose; FM20
Impaired GlucoseTolerance IIGT); FM20
Implantable Cardioverter Defibrillators; C22
Incapable; ELOAM17
Incidence; PH11
Increased ICP; ER31
Increased Intracranial Pressure iICP); ER5
Indeterminate Colitis; G20
InductionAgents; A25
Inductionof Labour; OB38
Infant Mortality Rate; PH10
Infection; GM6
Infectious Diarrhea; 1016
Infectious Diseases; RH3
Infectious Esophagitis; GB
Infectious Mononucleosis; FM45, P56
Infective Endocarditis; 1014, NP23
Inferior Vena Cava Filter; DM24
Infertility; GY23, U33
Infiltrating Ductal Carcinoma; GS52
Inflammatory Bowel DiseaseIIBD); GS25, G20, G30,
RH21
Influenza; 1012
Influenza Vaccination; ID12
Informed Consent; ELOAM13
Inglefinger's Sign; G48
Inhalation Injury; ER40
Inhalational Agents; A26
Insect Bites; ER20
Insomnia; FM42
Insulin; E3
Integrase Inhibitors; ID33
Integrated Prenatal Screen; OB7
Intention-To-Treat; PH9
Inter Ictal; N8
Intermittent Pneumatic Compression IIPC); H29
Internuclear Ophthalmoplegia; N26
Interpersonal Psychotherapy; PS41
Interstitial Cystitis; U9
Interstitial Disease; DM6
Interstitial Nephritis; NP27
Intestinal Ischemia; GS23
Intestinal Pseudo-Obstruction; G26
Intestitial Lung Disease; R11
Intra-Abdominal Abscess; GS9
Intracerebral Hemorrhage; NS4, NS17
Intracranial Aneurysms; NS18
Intracranial Hemorrhage; NS15
Intraductal Papilloma; GS50
Intrauterine Device (IUD); GY22
Intrauterine Feta! Death; OB45
Intrauterine Growth Restriction (lUGR\: OB29
Intravenous Urography (IVU), DM18
Intraventricular Hemorrhage: P71 , NS4. NS33
6 Index
Intussusception; DM15, P40
In-Vitro Fertilization; ELOAM13
InvasiveLobularCarcinoma; GS52
Iritis;RH4, RH21
IronDeficiency Anemia; Hl1
Iron Metabolism; H10
IrritableBowel Syndrome IIBS); G25
Ischemiailnfarction; C7
IschemicHeart Disease (IHD); C221, FM17
Ischemic NeurologicDeficit(RIND); NS19
IschemicStroke;N59
Insulin; FM22
IVFluid;A14
J
JacksonianMarch; N9
Joint Pathology; OR13
Jaundice; GS4, G43, G44, P68
JonesCriteria; P55
Justice; ELOAM6, ELOAM11
JuvenileIdiopathicArthritisIJIA); P92
K
KallmanSyndrome; N20
Kayser-Fl eischerRings; N33, G36
Kawasaki Disease; D45, ER43, P94
Keloid; D10, PL9
Keratoacanthoma;D7
Keratoconjunctivitis; RH1D
KeratodermaBlennorrhagicum; RH20
Kerley BLine; DM5, DM6
Kernicterus; G45, P69
Ketamine; A25
KidneyDisease; NP37
Kimmelstiel-Wilson NOdular
Glomerulosclerosis; NP35
Kleihauer-BetkeTest; 088
Klinefelter Syndrome; P44
Klumpke'sPalsy; PL18
Koebner Phenomenon; D4
Korsakoff's; PS21
Kussmaul'sSign; C44
L
Labour and Delivery; A23
Labyrinthitis; OTi 5
Lacerations; ER18,PL8
Lacunar Stroke; N59
Lambert-EatonMyasthenicSyndrome (LEMS); N45
Laminectomy; NS27
Lamotrigine; N12
Langerhans-Cell Histiocytosis; R14
LanguageDelay; P26
Laparoscopy; GY13
LargeBowel Obstruction; GS20
Laryngeal Cancer; OT36
Laryngeal Papillomas; OT30
Laryngitis; OT29
Laryngomalacia; OT46
Laxatives; GM13
LeFort Classification; PL28
LeadPoisoning; H12
LearningDisorders; P26
Left Anterior Fascicular Block; C6
Left Atrial Enlargement; C7: DM8
Left BundleBranch Block; C6
Left Posterior Fascicular Block; C6
LeftVentricular Fajlure; ER32
LeftVentricularHypertrophy; C7
LeftVentricular Enlargement; DM8
Legg-Cclve-PerthesDisease; OR39
Leiomyomata (Fibroids); GY38
Leiomyosarcoma; GY40
Leopold'sManoeuversIT3}; OB6
K L M
Leprosy; ID25
Lethargy; ER25
Leukemia; P84
Leukemoid Reactions; H8
Leukoplakia; D37
Level of Consciousness; NS5
Levetiracetam; N12
Lewy Body Disease; N15, N17
Lhermitte's Sign; N64
Lice; D31
Lichen Planus; D18
Lichen Sclerosis; GY47
Lichenification; D3
Light Chain Cast Nephropathy; NP34
LikelihoodRatio; PH10
Limb/BackPain; NS22
Ling Abscess; ID1 2
Lipodystrophy; ID33
Livedo Reticularis; RH11
Liver Abscesses; GS38
Liver Cysts; GS37
Liver Neoplasms; GS39
LiverTransplant; G40
LobularCarcinomainSitu(LCIS); GS52
Local Anesthesia; A2l
Loftier'sSyndrome; R14
Looseningof Associations; PS3
Looser's Zones; DM12
Low Back Pain; FM36
Lower Gastrointestinal Bleeding; G28
Lower UrinaryTract Syndrome (LUTS); U3, U4
Lumbar Disc Syndrome; NS26
Lumbar Puncture; N6, NS5
Lumbar Radicul opathy; OR22
LumbarSpinal Stenosis; NS27
Lupus Anticoagulant; RH11
Luteinizing Hormone (LH); E19
LymeDisease; ID26
Lymphedema; C53
Lymphoma; 84
Lynch Syndrome; G30
M
MAC(minimum alveolar concentration);A6
Macrolides; 1047
Macrocytic Anemia; H19
Macroglobulinemia ofWaldenstrom; H43
Macrosomia; 0830
Magi calThinking; PS3
Magnesium; E39
Magnetic Rel axationTimes (n andT2); DM3
Magnetic Resonance Angiography (MRA); NS19
Magnetic Resonance Imaging (MR); DM3
Major Anti -EpilepticDrugs; N12
Major DepressiveEpisode; PS8
Malabsorption;G16
Malaria; 1040
Maldigestion; G16
Malignant; OT17
Malingering; PS25
Mallampati Classification; A2
Mallet
Finger; PL14
Toe; RH7
MalloryWei ssTear; DM15, G27, G2B
Malnutrition; GM6, GM7
Malrotation of theIntestine; P35
Mammalian Bites; ER19
Mandibul arFractures; pl28
Manic Episode; PS8
Mantoux SkinTest; ID25
Marcus-Gunn Pupil; N27
Mastitis;OB54, FM48
Mastoiditis; ona
Maternal Mortality Rate; PH11
Maternal Serum Screen (MSSI; OB7
Maxillary Fractures; pl28
McCune-AlbrightSyndrome; E22
Mean Corpuscular Hb(MCH); H2
Toronto Notes 2008
Mean Corpuscular Volume IMCV); H2
Mean Platelet Volume (MPV); H2
Measles; D45, ER43, P58
Mechanical Valve; C40
Mechanical Ventilation; R28
Meckel'sDiveticulum; DM15, GS18
MeconiumAspiration Syndrome (MASI; P66
Mediastinal Mass; DM8
Medical Care Act; ELOAM2
Medical Error; ELOAM9
Medical Officer of Health; PH3
Medical Records; ELOAM19
Medicaid; ELOAM5
Medicare; ELOAM5
Medullary Sponge Kidney; NP37
Megaloblastic;H19, H20
Melancholic; PS9
Melanoma; D38
Melena; G26, G29
Memantine (Ebixa); N16
Meniere's Disease; OT14
Meningioma; NS11
Meningitis; ID7, ER31, P52
Meningocele (Spina Bifida Apena); NS33
MeniscalTears; OR30
Menjugate; ID8
Menopause; GY33, FM38
Menorrhagia; GY7
Menstrual Cycle; GY4
Mental HealthAct; ELOAM17, PS52
Mental HealthLegislation; ELOAM16
Mental Retardation (MR); P25
Meperidine; A25
Meralgia Paraesthetica; NS2a
Mesothelioma; R26
MetabolicAcidosis; ER48, NP1 8
MetabolicAlkalosis; NP19
MetabolicBone Disease; E44
MetabolicSyndrome; FM7
Metabolism; CPS
Metatarsal Fracture; OR37
MetastaticBoneTumours; DM11
MetastaticTumours; NS9
Metrorrhagia/Menometrorrhagia; GY7
Microalbuminuria; NP35
Microangiopathic HemolyticAnemia (MAHA); H1B
Microcytic;H3
Microscopic Polyangiitis; RH15
Middle Cerebral Artery Stroke; ER36
Migraine; ER31 , N55, P81, RH25
Milan Criteria; G40
MilkCaries; P11
MilkProtein Allergy; P38
Miller-Fisher Variant; N42
Mittleschmertz; G2
Mixed ConnectiveTissue Disease; RH15
MixedEpisode; psa
MixedHearingLoss; OT10
Modified GCS; ER41
Molluscum Contagiosum; D33
Monoclonallg Deposition Disease IMIDD);NP34
Monoclonal Gammopathyof Unknown
Significance (MGUS); H43
Mononeuropathy Multiplex; N40
Monro-Kellie Hypothesis; NS4
Monteggia Fracture; OR17
Morphea; D1D
Morphine; A25
MotorVehicle Collision; ER7
MR;C4l
MRCP; DM16, G52
MS;C41
MUGA Scan; DM22
Multifocal AtrialTachycardia; C17
MultipleEndocrineNeoplasm; E37
Multiple Myeloma; DM10, H42, NP22, NP25, NP34
Multiple Sclerosis; DM20, N57, NS4
Mumps; P59
Muscular Dystrophy (MD); P44
Muscle Relaxants; A7, A26
MVP;C42
TorontoNotes2008
MyastheniaGravis; N44
MycosisFungoides; D37
MyelodysplasticSyndromes (MDS); H31 , H33
Myelography; DM20
Myelomeningocele; NS33
Myocardial Perfusion Scanning; DM22
Myocarditis; C39
Myoclonic; N10
Myoclonus; N37
Myofascial PainSyndrome; RH25
Myopia; OPS
Myotonic Dystrophy; N46
MyxedemaComa; E28
N
Naloxone; ER47
Narcolepsy; FM42
Nasal Fractures; PL29
Nasal Obstruction; OT8
Nauseaand Vomiting; GM11, Al l, NS5
NeckMasses; OT32
Necrotizing Enterocoli tis; DM13, P70
Necrotizing Fasciitis; PL24
NegativePredictiveValue;PH10
NegativeReinforcement; PS41
Neglect; P15
Negligence; ELOAM15, ELOAM19
Nematodes; 1042
Neologism; PS3
Neonatal AlloimmuneThrombocytopenia
Purpura (NATP); P70
Neonatal Care; P61
Neonatal Resuscitation; P62
Nephritic Syndrome; P76, NP20
Nephrotic Syndrome; NP21 ; P76
NephroblastomaIWilm'sTumour); U37
NephrogenicDI; E19
Nerve Conduction Velocities(NCV); NS27
NerveGrafting; PL7
Neuroblastoma;P85
Neurofibromatosis; D40, P83
Neurogenic Bladder; U6
NeurogenicClaudication; NS22, NS27, FM37
NeurolepticMalignant Syndrome; PS44
Neuroleptics; PS42
NeurologicallyDeterminedDeath; NS32
Neurological Examination; N4
Neuromuscular Junction Disease; N44
NeuropathicPain; N51
Neurotization; PL7
Neutropenia; H7
Neutrophilia; H7
Nevus Sebaceus; 010
Niacin; E53
NicotineReplacementTherapy; FM9
Nightstick Fracture; OR18
Nocturnal PenileTumescenceand Rigidity; FM28
Nodular Pattern; DM6
Non-AlcoholicFattyLiver Disease(NAFLD);G38
Non-Articular Rheumatism; RH24
Non-Hodgkin's Lymphoma; H38, H40
Non-Maleficence; HOAM6
Non-NucleosideReverseTranscriptaseInhibitors
(NNRTls); 1033
Non-Rebreather Mask; Al0
Non-Toxic Goitre; E29
Non-SCLC; R3l
NoonanSyndrome; P44
Normal Distribution; PH14
Normal Pressure Hydrocephalus INPH);NS7
Normocytic; H3
NPH; N1 5
NSAIDs;A18, NS27
NSAIDlnducedUlceration; G11, G53
STEMI; C25
Nuclear Cardiology; Cll
NucleosideReverseTranscriptaseInhibitors(NRTls);
ID33
M N 0 P
NucleotideReverseTranscriptaseInhibitors; 1033
Number NeededtoHarm; PH19
NumberNeededtoTreat; PH19
Nummular Dermatitis; D17
Nutrition; FM4
Nystagmus; OP36. N47, N58
o
Obesity; E16, P10. FM5
Obsession; PS3, PS14
ObsessiveCompulsiveDisorder (OCO) andADHD;
N37
Obstetrical Anesthesia; A22
ObstructiveShock; ER3
Obstructive SleepApnea; FM42, R33
Occupational Health; PH22
OculocephalicReflex; N7
OddsRatio; PH9, PH18
OdontoidView; ERl l
Odynophagia: G4
Ogilvie'sSyndrome; GS23
Olecranon Fracture; OR16
Oligohydramnios; OB31
Olivopontocerebellar Atrophy (OPCA);N48
Onycholysis; RH21
OpenFractures; ER16
OpenPneumothorax; ER12
OphthalmologicForeignBody; ER33
OpioidAnalgesicEquivalencies; CP16
Opioid Antagonists; A19
Opioids: A.18,A25; CP17
OpportunisticInfections; ID32
OpticDisc Edema; N25
OpticNeuritis; N24
Oral AntihyperglycemicAgents;E5
Oral Hai ry Leukoplakia; ID30
Oral Hypoglycemics; FM22
Orbital ApexSyndrome;PL30
Orbital Blow-Out Fractures; PL30
OrbitalCellulitis;OP1l
Osgood-SchlatterDisease; OR40
OsmoticDiuretics; NP38
Ossificationof PosteriorLongitudinal Ligament
(OPLL); NS4
Osteoarthritis; FM38
Osteolysis;RH21
Osteomalaci a; DM12, E46
Osteomyelitis; DM11, OR8
Osteoporosis;DM11, E44, RH21 , FM39
Osteosarcoma; OM10
Ostomies; GS33
Otalgia; OT6
OtitisExtema; FM47; OT17
Otosclerosis; OT19
OttawaAnkleRules; ER17
OttawaCharter for HealthPromotion; PH6
OttawaKneeRul es; ER17
Outbreak; PH14,PH15
OvarianTumours; GY4l
Overvalued Ideas; PS3
OxygenSaturalionGap;ER48
Oxygenation; A10
p
P-glycoprotein(pqp]: CP4
Pacemaker; C21
Paget' sDisease; GS52
Paget'sDisaase of Bone; DM12, E48
Pain;GM11,N65
PainSyndromes; N50
Palliative; GM10
Palpitations; E5
PancoastTumour; N28; R31
PancreaticCancer; GS47
Pancreatitis; DM16, 17; GM, 46, 48, 49;GS46
Index 7
Pancytopenia; H6
PanicAttacks; PS12, PS13
Panniculitis; RH10
Pap Smear; GY45
ParalyticIleus; GS22
ParaneoplasticNeuropathies; N43
Paraneoplaslic Syndromes; R31
Paraphasias; N18
Paraphimosis; U29
Parasite; 105
ParasympatheticNervous System(PNS);
CP14, CP16
ParathyroidHormone(PTH);E39, E54
Parenteral Nutrition; G51
Paresthesias; RH25
Parkinson'sDisease; N30
Parkinsonism; N30
Parkland Formul a; ER20, PL21
Paronychia; PL25
Paroxysmal Nocturnal Hemoglobinuria(PNH);H11
Parti al (Focal) Seizures; N8, Nl0
Partiti onCoefficient ; CP3
Patausyndrome; P43
PatellarDislocation; OR32
PatellarFracture; OR33
PatellarTendonRupture; OR3l
Patellofemoral Syndrome; OR32
PatentDuctusArteriosus(PDA);P2l
Patient ControlledAnalgesia(PCA); A19
Patterson-KellySyndrome; G7
PectusExcavatum; DM8
PediatricOrthopaedics; OR37
PelvicFracture; OR24
PelvicInflammatory Disease(PlO); GY30
Pelvic Mass; GY9
Pel vic Pain; GY9, ER22
Pel vicRelaxationlProlapse; GY35
Pemphi gusVulgaris; 022
Penicillins; ID46
Peptic Ulcer Disease(PUDI; G9; GS13
PercutaneousBiliaryDrainage(PSD);DM25
Percutaneous Biopsy; DM25
PercutaneousCoronaryIntervention(PC!); C29
PercutaneousTransluminal Angioplasty; DM24
Pericarditis; C8, C43
Pericardial Effusion; MD8, C43
Peribronchi al Cuffing; DM6
Periodic HealthExamination(PHE); FM2
Periostiti s;RH21
Peripheral Arterial Disease; C45
Peripheral Arthritis; RH21
Peripheral NerveInjury; NS27
Peripheral Neuropathy; N39; NS22
Peripheral VenousDisease; C51
Peritoneal Dialysis;NP32
Peritonitis;ER24
Peritonsillar Abscess; OT42
Pernici ousAnemia; H20
Perseveration; PS3
Persistent PulmonaryHypertensionof the
Newborn; P67
PersistentVegetativeState;N8
Pertussis; P56
Peyronie'sDisease; U28
Pharmacodynamics; GM1 2,CP3, CP8, CP14
Pharmacokinetics; GM11 , CP3,CP7, CP8, CP13
Pharyngitis; P54
Phases of Clinical Testing; CP2
Phenylketonuria; P46
Phenytoin; N12
Pheochromocytoma; E36
Philadelphiachromosome (Phi; H35
Phimosis; U29
Phl ebotomy; G37
Phosphorus;E39
Physician-AssistedSuicide;ELOAM13
Physician-PatientRelationship; ELOAM11
Physiotherapy (PT]: NS25
Pick Bodies; N17
Pick'sDisease; N15
8 Index
PIE Syndrome; R14
Pilonidal Disease; GS36
Pinworm; 1043
PituitaryAdenoma; E20, NS11
PituitarvApoplexy; EE20
Pituitary Hormones;E17
Pityriasis(Tineal Versicolour; 035
Placenta Previa; 0823
Plantar Fasciitis; OR36, RH20
Plasma Osmolar Gap; ER48
Plasma CholinesteraseDeficiency; A7
Plasma Para-Aminohippuric Acid (PAH);NP3
Plasmodium spp; ID40
Pl eural Effusion; DM?, R23
Plicae Circulares; G12
Plummer-Vinson; G7
Plummer'sDisease; E25
Pneumonia; 1010, Paa
PneurnocvstisJirovecii Pneumonia; 1000, ID31
Pneumoconiosis; DM6, R16
Pneumocystis Jiroveci; ID36
Pneumothorax; DM?, R25
Pneumovax; 108
Podagra; RH22
Poi kilocytosis; H3
Polvarteritis Nodosa; RH17
Polycystic Kidney Disease IPCKD); NP6, 36
Polycystic Ovarian Syndrome (PCOS); GY24
Polycythemia Rubra Vera (PRV) ; H5, H34
Polyhydramnios; OB30
PolymyalgiaRheumatica; RH17, RH25
Polymyositis/Dermatomyositis; N46; RH12,
R1-I13, RH25
Polypharmacy: GM12
Polyps; G29
Polysomnography; R34
PontineMicturition Center (PMC); U6
Population Health; PH2
Population Health Model; PH4
Porphyria CutaneaTarda; D23
Port Score; ID11
Portacath ''' ; DM24
Portal Hypertension; DM16, G37, G41, G45
PositiveEnd Expiratory Pressure (PEEP); R28
Positive Predictive Val ue; PH10
Positive Reinforcement; PS41
PositronEmissionTomography Scans IPETI; DM3
Pos1erior Cerebral Artery Stroke; ER36
Posterior CordSyndrome; NS25
Postmenopausal bleeding; GY7
Post Ictal; N8
Post-Operative Dyspnea; GS7
Post-Operative Fever; GS5
Post-Streptococcal Glomerulonephritis; P76
Post-test Probability; PH9
Post Obstructive Diuresis(POD); U7
Posterior Urethral ValvesIPUV); U35
Posterior Vitreous Detachment IPVD); OP24
PostherpeticNeuralgia; N52
Postpartum Care; OB51
Postpartum HemorrhageI,PPH}; OB52
Postpartum E25
PotentialYears of LifeLost; PH8
Potency; CPB, crs
Power of Attorney; ELOAM18
Prader-Willi Syndrome; PM
Pre-Diabetes; E3
Pre-excitationSyndromes; Cl ?, C19
Pre-test Probability; PH9
PrecociousPuberty; P31
Predominantly Cutaneous Vasculitis; RH15
Pregaballn; N12
Pregnancy Induced Hypertension(PIH); ER32
PrematureBeats;C17
PrematureEjaculation; U31
Premature Rupture of Membranes (PROM); 0841
Premature Ventricular Contraction; C20
Premenstrual Dysphoric Disorder; GY5
Premenstrual Syndrome; GY4
P Q R
Presbycusis; OT20
Presbyopia; OP10
Preseptal Cellulitis; OP11
Pressure Ulcers; GM6, GMa
Preterm Labour {PTLI; 0840
Prevalence; PH11
Prevnar; ID8
Priapism; U29
Primary Biliary Cirrhosis (PBCI; GM, G45
Primitive NeuroectodermalTumour; NS36
Primary Hemostasis; H21 , H23
Primary Prevention; PH5
PrimitiveReflexes; P4
Prinzmetal's Angina; C24
Privacyof Health Information; ELOAM19
Procedural Sedation; ER51
Progressive Pseudobulbar Palsy; N39
Progressive Systemic Sclerosis; RH11
Prolactin (PRL); E19
Propofol; A25
Proportional Mortal ityRatio; PH11
Prostate SpecificAntigen (PSA); U23
Prostatic Carcinoma; U21
Prostatitis/Prostatodynia; FM26; Ul0
Protease Inhibitors(Pis); ID33
Protein Binding; CP4, CP5
Proteinuria; P75, NP4
Protozoa; ID5
Pruritus; GM11
Pseudo-Obstruction; GS22
Pseudogout;RH22, RH23
Pseudoseizure; N11
Pseudoturnour Cerebri; N25, NSB
Psoriasis; 019, RH21
PsoriaticArthritis; RH21
Psychoanalysis; PS40
Psychosis; ER45, PS4
Ptosis; OP14
Puberty; P17
Public Health; PH2
Public Health Agency of Canada; PH3
PublicHealth Unit; PH20
PublicGuardian andTrustee; ELOAM1?, ELOAM18
Pulmonary Arteri al Catheter; R34
Pulmonary Contusion;ER13
Pulmonary Edema; C34, DM6, ER29
Pulmonary Embolism; DM4; C9; H29; R19
Pulmonary FunctionTests; R3
Pulmonary Hypertension; R17
Pulmonary Nodule; DM6
PulmonaryStenosis; P22
Pulsus Alternans; ER29
Puncture Headache; A20
Punishment; PS41
Pupillary Changes; ER26
PureTone Audiometry; OT10
Purpura; 04
Pyelonephritis; FM26
Pyloric Stenosis; P35
Pyosis; G5
Pyrophosphate Scintigraphy; DM22
Q
Quadrantanopsia; N25
QualityAdjusted LifeYear; PH10
Qualityof Life; GM10
Toronto Notes 2008
R
Rabies; ID9, ER20, pl10
Radial HeadFracture; OR16
Radical Prostatectomy; U40
Radioactive Iodine Uptake; DM21, E22
Radiofrequency (RF) Ablation; DM25
RadioiodineAblation; DM21
RadionuclideVentriculography; DM22
Randomized ControlledTrial; PHI8
Rapid Sequence Induction; A9
Rapidly Progressive Glomerulonephritis
IRPGN); NP21
Raynaud'sPentad; G46
Raynaud'sPhenomenon; 041; RH12, RH4
Reactive Arthritis; RH20
Recall Bias; PH17
Rectal Prolapse;GS36
Recurrent Abdominal Pain; P41
Red Blood Cell (RBCI; H2
Red BloodCell DistributionWidth (ROW); H2
Red Eye; 0P3
Red Man Syndrome; ID47, CP13
Reed-Sternberg Cell; H3, H3B, H39
Regional Anesthesia; A19
Regression; PH13
Relationship; ELOAM11
Relative AfferentPupillaryDefect; N27
RelativeRisk;PH9, PH18
Relative RiskReduction; PH19
Reliability; PH13
Renal Adenocarcinoma (Renal Cell Carcinoma
(RCC); U18
Renal Artery Stenosis; NP27
Renal BloodFlow (RBF); NP3
Renal Colic; U14
Renal Cysts; U17
Renal Osteodystrophy; E47
Renal Plasma Flow (RPF); NP3
Renal Scan; DM18
RenalTransplantation; NP32
Renal VeinThrombosis; NP28
Renovascular Hypertension; NP33
Reportable Diseases; PH28
Residual; PS3
Respiratory Acidosis;R5
RespiratoryAlkalosis; R5
Respiratory Distress intheNewborn; P64
Respiratory Distress Syndrome (RDSI; P65
Respiratory Failure; R26
Restless Leg Syndrome; FM42
Restrictive Cardiomyopathy; C38
ReticularPattern; DM6
Reticulonodular Pattern; DM6
Retinal Detachment; OP27
Retinoblastoma; OPM
Retinopathy of Prematurity(ROP); OPM, P71
RetrogradePyelography; DM18
Retrograde Urethrogram; DM18
Reye'sSyndrome; G38; P59
Rhabdomyolysis; ER24
Rhabdomyosarcoma; P86
Rheumatic Fever; C40, P55
Rheumatoid Arthritis; RH5, RH6
RheumatoidHand; PL18
Rhinitis; OT23, OT24
Rhinitismedicamentosa ; FM12
Rickets; DM12, E46
Riedel's Struma; E28
Right Atrial (RA) Enlargement; C7; DM8
Right Bundle Branch Block; C6
RightVentricular Hypertrophy; Cl
RightVentricular (RV) Enlargement; DM8
Rigler's Sign; DM8
Ring Enhancing Lesion; DM20
Ring Sideroblasts; H13
Rivastigmine IExelon
TO
); N16
Rochester Criteria; ER42, PSO
ToronloNotes 2008
Rocky MountainSpotted Fever; 1028
Rolando's Fracture; PL16
Rosacea; 013
Roseola; 045, P58
Rotator Cuff Disease; OR12
Rouleaux; H3, H42
Routes of Drug Administration; CP2
Rubella; 045, P59
Rule of 9's; ER20
Russell'sSign; PS30, PS31
S
Sacrciliitis;RH19, RH21
Safety; CP11
Sal ivaryGland Neoplasms; OT31
Salter-Harris Classification; OR38
Sarcoidosis; DM5; R13, G9, NP25
Sacroiliitis; RH18
Saturday Night Palsy; NS28
Scabies; 031
Scaphoid Fracture; OR19, ER17
Scarlet Fever; 045, P55
Schatzki Ring; G7
SchillingTest; G18, H20
SchirmerTest; RH14
Schistocytes; H3
Schistosoma spp.; 1041
Schizoaffective Disorder; PS3
Schizophrenia; PS4
SchizophreniformDisorder; PS6
Schwachman-Oiamond Syndrome; P39
Scleritis; OP18
Sclerodactyly; RHll
Scleroderma; G4, G6, G26, RH5, RHll, NP28
Sclerosing Cholangitis; G44, G46
Scoliosis;OR40
Scotoma; N25
SOM; ELOAM16, ELOAM17
Sebaceous Gland; 02
Seborrheic Dermatitis;018
Seborrheic Keratosis; 06
SecondaryBiliary Cirrhosis; G46
Secondary Hemostasis ; H21
Secondary Prevention; PH5
Secondary Survey; ER5
Seizure; N8, ER24, ER35, P78
Sel ectiveEstrogen Receptor Modulations; E54
Seminoma 135%); U24
Sensitivity; PH10
Sensorineural Hearing Loss; ono,0T19
Sentinel Loop; G49
Sepsis; R36, 1024
Sepsis intheNeonate; P63
Septal Hematomas; PL29
Septic Arthritis; 1022
Septic Joint; OR8
SepticShock; 1024
Seronegative; RH4
Seropositive; RH4
Seropositive Rheumati cDiseases; RH15
SerotoninSyndrome; PS48, ER50
SevereAcute Respiratory Syndrome (SARS);
1013,1014
SevereRespiratoryIllness (SRI); 1013
SexualAssault ; ER34
Sexual Dysfunction; GY32
SexuallyTransmittedInfections (STls); GY27, FM40
SezarySyndrome; 037
Shaken Baby Syndrome; ER44
Shawl Sign; RH13
Shock; A12, ER3
ShortStature; P33
Shoulder Dislocation; OR10
Shoulder Dystocia; OB47
Shunt Nephritis; NP23
ShyDrager Syndrome; N30
Sialadenitis; 0130
Sialolithiasis; OT31
Sicca; RH4, RH14
R 5 T
Sick Euthyroid Syndrome; E28
Sick Sinus Syndrome; C15
Sickl eCell;H3, H17; NP25; P47
Sideroblasti cAnemia; H12
Sideroblasts; H3
Silhouette Sign; OM5
Simple partial seizures; N8
Sinus Arrest; C15
Sinus Arrhythmia; C15
SinusBradycardia; C15
SinusPause; C15
SinusTachycardia; C17
Sinusitis; OT26, OT27, FM42, FM47
Sipple's Syndrome; E37
Sjiigren'sSyndrome; NP25; RH14
Skin Grafts; PL11
Skull Films; OM19
Skull and Facial Bones; PL4
Skull Fractures; ER8, NS30
SLE; N15, N35
SleepApnea; R33, RH25
Sleep Disorders; FM42
Sleeping Medications; GM14
Slipped Capital Femoral Epiphysis; OR38
Small Bowel Obstruction; GS20, G48
Small Cell Lung Cancer; R31
Smith'sFracture; OR19
Smoking Cessation; FM8
SmudgeCells; H3, H41
Snake Bites; ER20
Snowball Sign; OM5
Soci al Phobia; FM42
SolubleTransferrinTeceoptor (STfR); H11
Somnambulism; FM42
Sonohysterography; GY10
SoreThroat (Pharyngitis); FM45
Spasticity; N65
Speech Audiometry; OTll
Specificity; PH10
SpermatoceleJEpididymal Cyst; U28
Spherocyte; H3
SPIKES Protocol; ELOAM10
Spinal Anesthesia; A20
Spinal Cord Syndrome; N57
Spinal Dysraphism; NS33
Spinal Muscular Atrophy; N39
Spinal Stenosis; OR22
Spinal Trauma; ER9
Spine; OR20
SpinocerebellarAtaxia; N48
Spironolactone(Aldactone1" ); NP38
Spl enectomy/SplenicTrauma; GS48
Splenomegaly; G32
SplitThickness Skin Graft; PL11
Spondylitis;RH21, RH21
Spondylosis; OM21
Spondylolisthesis; OR24
Spondylolysis; OR24
Squamous Cell Carci noma; 039
STSegmentChanges; E5
Stab Wounds; ER7
Stagesof Change; PH7
Stagesof Puberty; GY3
Standard Deviation;PH14
Stasis Dermatitis; 018
Statins; FM7
Statistical Significance; PH12
Status Epil epticus;N1 2
Steady State; CP7
Steele-Richardson-Olszewski Syndrome; N30
STEMI; C26
Stenosing Tenosynovitis; PL15
Stereotactic Radiosurgery ISRS); NS11, NS21
Stevens-Johnson Syndrome; 024, CP13
Still's Disease; P92
Strabismus; OP41
Streptococcal (GAS) Pharyngitis; FM47, P55
Stress-Induced Ulceration;Gll
String Sign; G21
Stroke; N9, N57
StrokeSyndromes; ER26
Index 9
StrongyloidesStercoral is;1043
Stupor; ER25
Sturge-WeberSyndrome; P83
SubacuteThyroiditis;E24
Subarachnoid Hemorrhage; OM19, ER31, NS4, NS5,
NS15
Subdural Hematoma; OM19, NS14
Subglottic Stenosis; OT46
Submucosal Tear; DM15
Substance Abuse; PS20
Substance Dependence; PS20
Substance Intoxication; PS20
Substance Withdrawal; PS20
Substitute Decision Makers; ELOAM16
Subungual Hyperkeratosis;RH21
Succinylcholine; A26
Sudden Cardiac Death; C29
Sudden Infant Death Syndrome (SIDS); Pll
Suicidal Patient; ER46
Sulfa-ContainingMedications; CP12
Sulfa Drugs; CP13
Sulfonyflureas; E52
Superficial Thrombophlebitis;C51
Superior Orbital Fissure; PL30
SuperiorVena Cava Syndrome; R31
Supracondylar Fracture; ORIS
SupraventricularTachyarrhythmias; C17
Suturing; PL6
Swan Neck Def ormity; PL14, PL15; RH7
Syncope; ER36, NIl , FM24
Syndrome of InappropriateAOH Secretion
(SIADH); E19
Syndrome X;C24
Sympathetic Nervous System ISNS); CP14,
CP15, CP16
Sympathomimetics; ER50
Synovial Fluid Analysis; RH23
Syphilis; D28, 1026, GY29
Syringoma; 010
Syringomyelia; NS23,NS35
Systematic Desensitization; PS41
Systemic Inflammatory Response Syndrome
ISIRS); R36, 1024
Systemic LupusErythematosusISLE); RH5,
RH9, NP22
Systotic Dysfunction; C33
T
Takayasu'sArteritis; RH15
Talar Fracture; OR35
Tall Stature; P34
Tamm-Horsfall Protein; NP34
Tangentiality; PS3
Tanner Staging; P17
Target Cell; H3
TarsalTunnel; NS28
Teardrop Cell; H3
Telangiectasia; 04
Telogen Effluvium; 043
Temporal Arteritis; ER31
Temporal Bone Fractu res; OT21 , OT22
Temporal Lobe Epilepsy; N9
Tender Points; RH25
Tenosynovitis; RH7
Tensilon '" ; N27
Tension Headache; ER31
Tension Pneumothorax; DM7, ER1 2
Tension-Type Headache; N56
TesticularTorsion; U26
TesticularTumours; U24
Tetanus; 109, ER18, PL9, PL10
Tetracyclines; 1047
Tetralogy of Fallot; P22
Thalamic Pain; N53
Thalassemia; H15
Therapeutic Index (TI); CPll
Therapeutic Drug Monitoring (TOM); CPll
Thiamine; ER47
10 Index T u V W X
y
z Toronto Notes 200S
Thiazolidinedione; E52
A25
Tophi; RH22
Thoracic Outlet Syndrome; GS13, NS28
Thoracolumbar Spine; OR21
Though! Blocking; PS3
Thrombocytopenia; H5
Thrombocytosis; H6
Thrombolysis; N62
ThrombolyticTherapy; DM24
ThromboticThrombocytopenicPurpura (TIP); H24
Thumb Duplication; Pl34
Thumbprinting Sign; DM14
Thyroid; E21
Thyroid Carcicoma; 0137
Thyroid Gland; OT5
Thyroglossal Duct Cysts; 0133
Thyroid Nodules; E29
Thyrotoxi cCrisisfThyroidStorm; E25
TIbial Plateau Fracture; OR33
Tibial Shaft Fracture; OR33
TicDouloureux; N52
nMI Risk Score; C26
TInea CruriS/Pedis;FM48
Tinitus; OT16
Todd's Paralysis; N10
ToiletTraining; P12
Tonsiliectomy; OT43
Tonsillitis; P54
Topiramate; N12
Torsades dePointes; C20
Total Anomalous Pu Imonary Venous
Connection; P23
Total BodyWater;CP4
Total Iron Binding Capacity {TIBC); Hl0
Tourette'sSyndrome; N37
Towne'sView; DM19
Toxic AdenomafToxicMultinodular Goitre; E25
Toxic Epidermal Necrolysis; 024, CP13
Toxic Megacolon; GS22, G21
Toxic Shock Syndrome; 1027, GY32
Toxicology; ER46
Toxoplasma Gondii; ID41
Toxoplasma Gondii Encephalitis; 1031
Tracheoesophageal Fistula (TEF); P35
Transcranial Magnetic Stimulation ITMS); PS51
Transference; PS40
Transfusion;H44
Transient Synovitis; P92
TransientTachypneaof theNewborn (TIN); P66
Transitional Cell Carcinoma (TCe); U20
Transoesophageal Echocardiography; Cl0
Transposition of theGreat Arteries (TGA); P23
Transthoracic Echocardiography; Cl0
Transudative Pleural Effusions; R23
Transurethral Resection of the Prostate (TURP);
U40
Trauma; ER6
Traveller'sDiarrhea; 1018, G15
Tremor; N34
Trichomonas Vaginal is; 1039
Trichomoniasis; GY27
Triple BolusTest; E20
Truncus Arteriosus; P24
Trypanosoma Cruzi; 1039
Tuberculosis; 1024
Tuberous Sclerosis; P83
Tubular Secretion; CP6
Tubulointerstitial Nephritis ITIN);NP24, NP25
Tumour Lysis Syndrome; H44
Tumours of Small Intestine; GS17
Turner Syndrome; P44
Twin-TwinTransfusion Syndrome; OB29
Tympanogram; OT11
Type 1Diabetes; E3, P27
Type 2Diabetes; E3, FM20
Type I Error; PH12
Type 11 Error; PH12
U
Uhthoff's Phenomenon; N64
Ulcerative Col itisIUCI; G13, G20, G21, G24, G26,
G30; RH21
Ulcers; PL26
Ulnar Nerve Entrapment at Elbow; NS28
Ultrasound (U/SI ; DM2
Umbilical Cord Prolapse; OB47
Undifferentiated Spondyloarthropathy; RH21
Unfractionated Heparin (UFH); H29
Univentricular Heart (singleventricle); P23
Universal Antidotes; ER25
Unstable Angina; C25
UPJ Obstruction; U36
Upper Gastrointestrnal Bleeding; G26
Urea BreathTest; Gl1
Uremic Syndrome; NP28
Urethral Stricture; U6
Urethritis; U12. FM26
Urinalysis; NP7
Urinary Incontinence; GM6, GM9, GY37, U3
Urinary Retention; U4
UrinaryTract Infection (UTI); P60; U8
UrinaryTract Obstruction; DM18
Urine Albumin toCreatinine Ratio (ACR); NP4
Urine Electrolytes; NP9
Urine Microscopy; NP8
Urodynamic Studies; U7
Urogynecology; GY35
Urticaria; 025
UTI/cystitis; FM26
Uterine Sarcoma; GY40
Uterine Rupture; OB48
Uveitis; opn
v
VlO Scan; DM21
Vaginal Birth AlterCaesarean (VBAC); 0844
Vaginal Bleed; ER37
Vaginal Candidiasis; FM48
Vaginal Discharge/Pruritis; GY8
VaginalIntra-Epithel ial Neoplasia; GY49
Vaginitis; FM26, FM48
Vagus Nerve; N23
Validity; PH13, PH19
Valvular Heart Disease; C41
Variance; PH14
Varicella; P57
Varicocele; U28
VaricoseVeins; C52
Vasa Previa; OB25
Vascular Claudication; NS22
Vascular Redistribution; OM6
Vasculitis; RH15
Vasodilators; ER33
Vasomotor ARF; NP26
VDRL; 1026
VenousThrombosis;H28
Ventricular Assist Devices; C33
Ventricular Fibrillation; C21
Ventricular Premature Beat; C20
Ventricular Septal Delect IVSD); P20
VentricularTachyarrhythmias; C20
VentricularTachycardia; C20
Venturi Mask; A1D
Vertebrobasilar Artery Stroke; ER36
Vertigo; OT6, OT12, OT21 , N48
Vesicoureteral Reflux \VUR); U36
Vestibular Neuronitis; OT14
Vestibular Schwannoma ("Acoustic Neuroma");
NS11
Vestibulocochlear Response; N7
Viral Hepatitis; ID18
ViraI Load; ID29
Virchow'sTriadH 28
Virtual Colonoscopy; DM15
Virulence; PH14, PH15
Viruses; ID3
Visual Field Defects;N25
Visual Internal Urethrotomy (VIU); U6
Vitamin B" Deficiency; H19
Vitamin D;E39, E55
Vitamin KDeficiency; H26
Vitamins; FM4
Vitiligo; D40
Vitreous Hemorrhage; OP25
Vocal Cord Nodules; OT30
Vocal Cord Polyps; OT29
Voiding Cystourethrogram (VCUG); DM18
Volkmann's Ischemic Contracture; OR9
Volume of Distribution; CP8
Volvulus; DM14, GS32
Vomiting; G2
Vomiting intheNewborn Period; P35
Von HippelLindau; E36
Von Willebrand'sDisease (vWD); H25
Vulvar Intraepithelial Neoplasia; GY47
Vulvovaginitis; GY25
W
WAGR Syndrome; P85
Warfarin; H28, H48
Warfarin Overdose; ER51
Warts; 034
Water's View; DM19
Weakness; GM11
Web;G7
Wegener's Granulomatosis; R21, RH16,
NP23, NP25
Wells' Score; ER28
Wermer'sSyndrome; E37
Wernicke-Korsakoff; N15; PS21
Wernicke's Area; N18
Wernicke's Encephalopathy; PS21
West NileVirus; 1028, ER20
Westermark's Sign; ER28
Wet-To-Dry Dressing; PL7
Wheal; 03
Wheezing; ER27
White Blood Cell (WBC) Count; H2
Whole Brain RadiationTherapy (WBRT); NS10
Wilms'Tumour; P85
Wilson's Disease; N15, N33, G33, G36, RH4
Wireless Endoscopy Capsule; G52
Withdrawal; FM10
Wolff-Chaikoff Effect; E2
WOlff-Parkinson-White; C19
Women's HealthInitiative; GY35
WoodyThyroiditis; E28
World Health Organization (WHO);NS10
Wound Infection; GS6
Wound Closure; PL9
Wound Dehiscence; GS6
Wound Healing; PL8
x
Xanthelasmas; G45
Xanthochromia; N6
Xanthomas; G45
Xerosis: 03
Xerostomia; RHt4
z
Z-plasty; PL12
Zenker's Diverticulum; DM15, G6
Zollinger-Ellison Syndrome;G4, Gl0,G12, G53
ZygomaticFractures; PL29